Tags

Type your tag names separated by a space and hit enter

Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Fed Regist. 2003 Jun 09; 68(110):34273-93.FR

Abstract

The Food and Drug Administration (FDA) is issuing a final rule in the form of a final monograph establishing conditions under which over-the-counter (OTC) antiperspirant drug products are generally recognized as safe and effective and not misbranded as part of FDA's ongoing review of OTC drug products. FDA is issuing this final rule after considering public comments on its proposed regulation, issued as a tentative final monograph (TFM), and all new data and information on antiperspirant drug products that have come to the agency's attention.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

12795305

Citation

Food and Drug Administration, HHS. "Antiperspirant Drug Products for Over-the-counter Human Use; Final Monograph. Final Rule." Federal Register, vol. 68, no. 110, 2003, pp. 34273-93.
Food and Drug Administration, HHS. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule. Fed Regist. 2003;68(110):34273-93.
Food and Drug Administration, HHS. (2003). Antiperspirant drug products for over-the-counter human use; final monograph. Final rule. Federal Register, 68(110), 34273-93.
Food and Drug Administration, HHS. Antiperspirant Drug Products for Over-the-counter Human Use; Final Monograph. Final Rule. Fed Regist. 2003 Jun 9;68(110):34273-93. PubMed PMID: 12795305.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antiperspirant drug products for over-the-counter human use; final monograph. Final rule. A1 - ,, PY - 2003/6/11/pubmed PY - 2003/6/14/medline PY - 2003/6/11/entrez SP - 34273 EP - 93 JF - Federal register JO - Fed Regist VL - 68 IS - 110 N2 - The Food and Drug Administration (FDA) is issuing a final rule in the form of a final monograph establishing conditions under which over-the-counter (OTC) antiperspirant drug products are generally recognized as safe and effective and not misbranded as part of FDA's ongoing review of OTC drug products. FDA is issuing this final rule after considering public comments on its proposed regulation, issued as a tentative final monograph (TFM), and all new data and information on antiperspirant drug products that have come to the agency's attention. SN - 0097-6326 UR - https://www.unboundmedicine.com/medline/citation/12795305/Antiperspirant_drug_products_for_over_the_counter_human_use L2 - https://www.govinfo.gov/content/pkg/FR-2003-06-09/pdf/03-14140.pdf DB - PRIME DP - Unbound Medicine ER -